HCC1395 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HCC1395 cell line is a model derived from a human basal-like breast cancer, a subtype often associated with triple-negative breast cancer (TNBC). This cell line is known for its high genetic complexity, which includes significant genomic instability and a notable mutation profile typical of aggressive breast cancers. Studies focusing on HCC1395 have identified a considerable number of somatic mutations and copy number variations, contributing to its classification as a representative model for TNBC research. HCC1395 is especially relevant for exploring mechanisms underlying drug resistance and metastasis in basal-like breast cancers. One study highlighted the use of this cell line to evaluate the impact of silencing genes associated with cell migration, such as ZEB2, revealing that its downregulation could reduce the invasive potential of HCC1395. Additionally, this cell line's mutation landscape often includes alterations in genes related to DNA damage response and cell cycle regulation, such as TP53, which is frequently mutated in basal-like breast cancers. These characteristics make HCC1395 an important tool for preclinical studies that investigate new therapeutic strategies, including targeted and combination therapies aimed at overcoming resistance. By incorporating high-throughput sequencing and functional genomics approaches, researchers use HCC1395 to better understand TNBC pathophysiology, contributing to the development of more effective treatment regimens. |
|---|---|
| Organism | Human |
| Tissue | Breast |
| Disease | Carcinoma |
| Synonyms | HCC-1395, SCC-1395, Hamon Cancer Center 1395 |
Characteristics
| Age | 43 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Cell type | Epithelial cell |
| Growth properties | Adherent |
Regulatory Data
| Citation | HCC1395 (Cytion catalog number 305546) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1249 |
Biomolecular Data
| Protein expression | Epithelial glycoprotein 2 (EGP2), cytokeratin 19 |
|---|---|
| Oncogenes | Her2/neu-, p53+ |
| Mutational profile | Mutation: TP53, p.Arg175His (c.524G>A), homozygous |
Handling
| Culture Medium | RPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (820702a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with TrypLE Express, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305546-231025 | Certificate of Analysis | 05. Dec. 2025 | 305546 |